PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
1.01%
Revenue growth below 50% of CRON.TO's 30.43%. Michael Burry would check for competitive disadvantage risks.
51.22%
Cost growth above 1.5x CRON.TO's 30.89%. Michael Burry would check for structural cost disadvantages.
-129.16%
Gross profit decline while CRON.TO shows 28.11% growth. Joel Greenblatt would examine competitive position.
-128.87%
Both companies show margin pressure. Martin Whitman would check industry conditions.
3.64%
R&D growth less than half of CRON.TO's 12.56%. David Dodd would verify if efficiency advantage is sustainable.
-6.41%
G&A reduction while CRON.TO shows 3.43% growth. Joel Greenblatt would examine efficiency advantage.
-24.16%
Both companies reducing marketing spend. Martin Whitman would check industry trends.
-1.99%
Other expenses reduction while CRON.TO shows 3815.38% growth. Joel Greenblatt would examine efficiency.
-8.97%
Operating expenses reduction while CRON.TO shows 2.54% growth. Joel Greenblatt would examine advantage.
24.32%
Total costs growth above 1.5x CRON.TO's 13.93%. Michael Burry would check for inefficiency.
-66.53%
Interest expense reduction while CRON.TO shows 0.00% growth. Joel Greenblatt would examine advantage.
1.35%
D&A growth while CRON.TO reduces D&A. John Neff would investigate differences.
-2230.01%
Both companies show EBITDA decline. Martin Whitman would check industry conditions.
-37.31%
EBITDA margin decline while CRON.TO shows 23.29% growth. Joel Greenblatt would examine position.
-2648.08%
Both companies show declining income. Martin Whitman would check industry conditions.
-2620.65%
Operating margin decline while CRON.TO shows 19.04% growth. Joel Greenblatt would examine position.
100.80%
Other expenses growth above 1.5x CRON.TO's 28.11%. Michael Burry would check for concerning trends.
-1544.98%
Pre-tax income decline while CRON.TO shows 51.33% growth. Joel Greenblatt would examine position.
-1528.57%
Pre-tax margin decline while CRON.TO shows 62.68% growth. Joel Greenblatt would examine position.
7.70%
Tax expense growth while CRON.TO reduces burden. John Neff would investigate differences.
-1840.05%
Net income decline while CRON.TO shows 80.33% growth. Joel Greenblatt would examine position.
-1820.69%
Net margin decline while CRON.TO shows 84.92% growth. Joel Greenblatt would examine position.
-1840.00%
EPS decline while CRON.TO shows 80.37% growth. Joel Greenblatt would examine position.
-1840.00%
Diluted EPS decline while CRON.TO shows 80.37% growth. Joel Greenblatt would examine position.
0.63%
Share count reduction below 50% of CRON.TO's 0.04%. Michael Burry would check for concerns.
0.63%
Diluted share reduction below 50% of CRON.TO's 0.04%. Michael Burry would check for concerns.